Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Stifel analyst Nathan Jones initiated coverage on American Axle & Manufacturing Holdings, Inc.

PHILADELPHIA, June 26, 2025 ( GLOBE NEWSWIRE ) -- Kaskela Law LLC announces that it is investigating Trevi Therapeutics, Inc. TRVI ( "Trevi" ) on behalf of the company's long-term investors.

Data from a mid-stage study shows that treatment with Trevi's experimental drug reduced patients' 24-hour cough frequency by 57% over placebo.

Haduvio reduced 24-hour cough frequency by 67% from baseline and 57% vs. placebo in Trevi's Phase 2a trial for refractory chronic cough. 84% of Haduvio patients saw at least a 30% cough reduction vs. 29% on placebo. Find out which stock just plummeted to the bottom of the new Benzinga Rankings.

Trevi Therapeutics (TRVI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).